Your browser doesn't support javascript.
loading
Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron.
Liu, Hejun; Kaku, Chengzi I; Song, Ge; Yuan, Meng; Andrabi, Raiees; Burton, Dennis R; Walker, Laura M; Wilson, Ian A.
Afiliação
  • Liu H; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Kaku CI; Adimab, LLC, Lebanon, NH, USA.
  • Song G; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Andrabi R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Walker LM; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Wilson IA; Adimab, LLC, Lebanon, NH, USA. laura.walker@adimab.com.
Commun Biol ; 5(1): 766, 2022 07 29.
Article em En | MEDLINE | ID: mdl-35906394
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article